Albemarle (ALB, Financial) experienced a significant stock price decline of 5.05%, trading at $102.72 per share with a trading volume of 893,799 shares. The turnover rate was 0.76% with a price fluctuation of 5.80%.
Recent financial reports revealed Albemarle recorded a revenue of $1.355 billion, a net loss of $1.069 billion, and an earnings per share (EPS) of -$9.45. The gross profit was -$104 million, resulting in a price-to-earnings (P/E) ratio of -6.14. Among the 27 institutions providing ratings, 37% recommended buying, 52% suggested holding, and 11% advised selling.
Within the chemical products industry, the overall gain was 0.16%. Notable performers included Alto Ingredients, Inc., Senestech, Inc., and FutureFuel, each showing significant growth. Active stocks included Crown Electrokinetics Corp. with a turnover rate of 5.94%, Danimer Scientific, Inc. with 3.80%, and Zhongbei Energy with 2.20%. Stocks with significant price swings included Danimer Scientific, Inc. at 30.12%, Crown Electrokinetics Corp. at 14.38%, and Senestech, Inc. at 11.65%.
Albemarle is a leading global lithium producer, largely driven by demand from battery applications, especially for electric vehicles. The company is fully integrated in lithium production with resources in Chile, the United States, and Australia. Albemarle operates lithium refineries in Chile, the U.S., Australia, and China and is a global leader in the bromine industry, used as a flame retardant, as well as a major oil refining catalyst producer.
